China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. Wednesday, Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback